Bolt Biotherapeutics ( NASDAQ:BOLT ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.14m (down 55% from...
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of -11.11% and 12.30%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?